Atypical Antipsychotic

Bipolar Disorder

Schizophrenia

<section class="Section" data-sectioncode="34089-3"><a name="section-11"></a><h1>11      DESCRIPTION</h1>The active ingredient of VRAYLAR is cariprazine, an atypical antipsychotic, in hydrochloride salt form. The chemical name is  trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hydrochloride; its empirical formula is C 21H 32Cl 2N 4O•HCl and its molecular weight is 463.9 g/mol.  The chemical structure is: <img alt="The chemical structure for VRAYLAR is cariprazine HCl, an atypical antipsychotic. The chemical name is trans-N-{4-[2-[4-(2,3 dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hyd" src="vraylar-01.jpg"/>VRAYLAR capsules are intended for oral administration only. Each hard gelatin capsule contains a white to off-white powder of cariprazine HCl, which is equivalent to 1.5, 3, 4.5, or 6 mg of cariprazine base. In addition, capsules include the following inactive ingredients: gelatin, magnesium stearate, pregelatinized starch, shellac, and titanium dioxide. Colorants include black iron oxide (1.5, 3, and 6 mg), FD&amp;C Blue 1 (3, 4.5, and 6 mg), FD&amp;C Red 3 (6 mg), FD&amp;C Red 40 (3 and 4.5 mg), or yellow iron oxide (3 and 4.5 mg). </section>

Vraylar

cariprazine

cariprazine 6 MG Oral Capsule

cariprazine 6 MG Oral Capsule [Vraylar]

Psoriasis (PsO)

Psoriatic Arthritis (PsA)

Ankylosing Spondylitis (AS)

Nonradiographic Axial Spondyloarthritis

Taltz

Juvenile Idiopathic Arthritis

Hidradenitis Suppurativa (HS)

Cosentyx

Siliq

Tremfya

Crohn's Disease (CD)

Ulcerative Colitis (UC)

Stelara

Skyrizi

Ilumya

Migraine

Cluster Headache

Migraine Prevention

Emgality

Qulipta

Acute Migraine

Ubrelvy

Nurtec ODT

Vyepti

Aimovig

Ajovy

Breast Cancer: HR+ (HER2-)

Verzenio

Ibrance

Kisqali

Atopic Dermatitis (Eczema)

Cibinqo

Eucrisa

Asthma (injectable)

Asthma OCS Dependent

Nasal Polyposis

Eosinophilic Esophagitis (EoE)

Prurigo Nodularis

Dupixent

Opzelura

Adbry

NSCLC ALK+ OR ROS1+ Disease

Lorbrena

Alecensa

Alunbrig

NSCLC cMET Mutation

Xalkori

Rheumatoid Arthritis (RA)

Xeljanz

Uveitis

Graft Versus Host Disease (GVHD)

Orencia

COVID-19 Treatment

Alopecia Areata

Olumiant

Multiple Sclerosis (MS)

Secondary Progressive Multiple Sclerosis

Zeposia

Rinvoq

Entyvio

Report Adverse Event 

Prescribing Information

Medication Guide 

Submit MSL Request 

Pharmacy List 

Formulary Coverage 

Online Sample Form 

Coverage Authorization Request 

Coverage Authorization Appeals 

Enroll in Patient Savings Program 

About Vraylar: Schizophrenia 

FAQs: Schizophrenia

Patient Resources: Schizophrenia 

Instructions For Use: Schizophrenia 

Doctor Discussion Guide: Schizophrenia

About Vraylar: Bipolar Disorder 

Patient Stories: Bipolar Disorder 

FAQs: Bipolar Disorder

My Mood Matters Support Program: Bipolar Disorder 

Patient Resources: Bipolar Disorder 

Instructions For Use: Bipolar Disorder 

Doctor Discussion Guide: Bipolar Disorder 

Patient Brochure: Bipolar Disorder

My Mood Tracker: Bipolar Disorder 

About Vraylar: Adjunct MDD

FAQs: Adjunct MDD

Instructions For Use: Adjunct MDD 

Symptom Tracker